mRNA SARS-CoV-2 疫苗首剂接种后 2 周发生脑静脉窦血栓。
Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.
机构信息
Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kota Bharu, Kelantan, Malaysia.
Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Health Campus, Jalan Raja Perempuan Zainab 2, 16150, Kota Bharu, Kelantan, Malaysia.
出版信息
Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362. doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.
严重急性呼吸综合征冠状病毒 2（SARS-CoV-2），也称为 2019 年冠状病毒病（COVID-19），是一种高度传染性病毒，已在全球流行。马来西亚政府防止疾病传播的措施之一是接种 COVID-19 疫苗。辉瑞/生物科技公司的疫苗使用信使 RNA 技术，是马来西亚药品管制局批准使用的疫苗之一。在此，我们报告首例接种辉瑞/生物科技公司疫苗后出现大脑静脉窦血栓形成的即刻并发症。
Zotero 插件